|
2025
|
Invention
|
Methods and agents for determining patient status.
Disclosed are methods and agents for predicti... |
|
|
Invention
|
Enhanced chimeric antigen receptor t cell composition and method of use. Disclosed herein are the... |
|
|
Invention
|
Prognostic signature for cancer recurrence and responsiveness. This invention relates generally t... |
|
|
Invention
|
Methods of treating multiple sclerosis using autologous t cells.
Provided herein are methods com... |
|
|
Invention
|
Methods of treating autoimmune disease using allogeneic t cells.
Provided herein are composition... |
|
2024
|
Invention
|
Combination therapy. This disclosure relates to combinations of tubulin polymerisation inhibitors... |
|
|
Invention
|
Cmv epitopes.
Provided herein are compositions and methods related to the treatment of a CMV inf... |
|
|
Invention
|
Biomarkers for age-related macular degeneration and uses thereof. Disclosed herein are methods fo... |
|
|
Invention
|
Cellular populations and uses thereof.
Disclosed are methods of identifying immunosuppressive TR... |
|
|
Invention
|
Determining a cancer prognosis.
Provided herein are methods of determining the aggressiveness, p... |
|
|
Invention
|
Glycoprotein biomarkers for ovarian cancer diagnosis. Disclosed herein are biomarkers for ovarian... |
|
2023
|
Invention
|
Human herpesvirus immunotherapy.
An isolated protein comprises respective amino acid sequences o... |
|
|
Invention
|
Compositions and methods for improved cancer treatment. This disclosure relates generally to comp... |
|
|
Invention
|
Anti-fibrotic microrna composition. Provided herein are compositions and methods for the treatmen... |
|
|
Invention
|
Methylation biomarker for infection resistance. Disclosed are methods for assessing the likelihoo... |
|
|
Invention
|
Engineered human cardiac tissue. The present application relates to methods for the generation of... |
|
|
Invention
|
Novel inhibitors of histone methyltransferase nuclear localisation. The present invention relates... |
|
2022
|
Invention
|
Immunogenic compositions and uses thereof.
The present invention discloses a novel recombinant p... |
|
|
Invention
|
"immunogenic compositions and uses thereof". The present invention discloses a novel recombinant ... |
|
|
Invention
|
Multivirus-specific t cell immunotherapy.
Provided herein are compositions and methods related t... |
|
|
Invention
|
Novel compositions and methods for treating coronavirus infections.
Disclosed are compositions a... |
|
|
Invention
|
Novel compositions and methods for treating coronavirus infections. Disclosed are compositions an... |
|
|
Invention
|
Immunotherapy for polyomaviruses.
Provided herein are methods and compositions related to polyom... |
|
|
Invention
|
Novel bicyclic peptides.
Disclosed are polypeptides which are covalently bound to molecular scaf... |
|
|
Invention
|
Novel bicyclic peptides. Disclosed are polypeptides which are covalently bound to molecular scaff... |
|
2021
|
Invention
|
Herpesvirus polyepitope vaccines.
Provided herein are compositions and methods comprising immuno... |
|
|
Invention
|
Herpesvirus polyepitope vaccines. Provided herein are compositions and methods comprising immunog... |
|
|
Invention
|
Methods of determining immune response.
The present disclosure relates generally to the field of... |
|
|
Invention
|
Methods of determining immune response. The present disclosure relates generally to the field of ... |
|
|
Invention
|
Treatment and detection of melanoma.
Provided are methods for determining or predicting the diag... |
|
|
Invention
|
Human cytomegalovirus polyepitope vaccine composition.
Disclosed is a human herpesvirus immunoth... |
|
|
Invention
|
Immune cells with enhanced function.
Disclosed are T-cells that are positive for CD49f and which... |
|
|
Invention
|
Compositions and methods for targeting hpv-infected cells.
Disclosed are compositions and method... |
|
|
Invention
|
Glycoprotein biomarkers for esophageal adenocarcinoma and barrett's esophagus and uses thereof. D... |
|
2020
|
Invention
|
Treatment of gastrointestinal disease.
Described herein are methods of protecting and/or promoti... |
|
|
Invention
|
Defective interfering particles.
The present disclosure relates to the production of transmissib... |
|
|
Invention
|
Cancer diagnostic.
The present disclosure relates to the field of cancer. More particularly, the... |
|
|
Invention
|
Adoptive immunotherapy.
Disclosed herein is the use of a first population of allogeneic T-cells ... |
|
|
Invention
|
Methods and agents for determining patient status. Disclosed are methods and agents for predictin... |
|
|
Invention
|
Activating anti-gal9 binding molecules.
Anti-GAL9 antibody constructs, pharmaceutical compositio... |
|
|
Invention
|
Anti-gal9 immune-inhibiting binding molecules.
Inhibitory anti-GAL9 binding molecules, antibody ... |
|
|
Invention
|
Method of treatment.
The present disclosure relates to methods for the treatment of cancer, meth... |
|
|
Invention
|
Cells, compositions and methods for enhancing immune function.
The present disclosure relates ge... |
|
2019
|
Invention
|
Rank antagonists and uses thereof.
Disclosed are antigen-binding molecules that antagonize one o... |
|
|
Invention
|
Viral detection assay.
Provided herein are methods for preparing and characterizing CTL cultures... |
|
|
Invention
|
Cardiomyocyte proliferation.
Provided herein are in vitro and in vivo methods of inducing cardio... |
|
2018
|
Invention
|
A combination of, or a bispecific binding molecule to, an immune checkpoint molecule antagonist a... |
|
2017
|
P/S
|
Computer software and application software relating to the
field of genomics including but not l... |
|
|
Invention
|
Immune status biomarkers and uses therefor.
Disclosed are compositions, methods, apparatus and k... |
